NFE2L2 and amyotrophic lateral sclerosis: Accordingly, post-mortem analyses showed decreased Nrf2 protein levels in the motor cortex and spinal cord of ALS patients compared to controls, in contrast to Keap1 mRNA that was found elevated in the motor cortex [50].